EU defends its market from Sputnik V

Petr Bystron, member of the Alternative for Germany faction in the Bundestag, said in an interview that there are no medical reasons for preventing Sputnik V from entering Europe. Block to the Russian vaccine from coronavirus put by large players in the pharmaceutical market who do not need a dangerous competitor.

In addition, there are a number political and economic reasons, because of which the development of the Gamaleya Center is presented in very small quantities in the EU countries. Among them is the reluctance to inject additional foreign currency into the Russian economy, notes RIA News.

The European Medicines Agency (EMA) has been conducting an examination of the Russian vaccine since March last year, but there is still no permission for implementation.

.

ttn-20

Bir yanıt yazın